<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="144659">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01955785</url>
  </required_header>
  <id_info>
    <org_study_id>2013/1346</org_study_id>
    <nct_id>NCT01955785</nct_id>
  </id_info>
  <brief_title>Respiratory Treatment of Patients With Moderate and Severe Traumatic Brain Injury</brief_title>
  <official_title>Respiratory Treatment of Patients With Moderate and Severe Traumatic Brain Injury: A Randomised Comparison of Pressure Controlled Ventilation and Pressure Regulated Volume Controlled Ventilation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <authority>Norway:National Committee for Medical and Health Research Ethics</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intracranial pressure (ICP) in patients with traumatic brain injury (TBI) is influenced by
      several factors of which one is arterial CO2 tension. Patient with TBI are often sedated and
      mechanically ventilated in order to secure a stable PaCO2. This study compares two
      ventilation modus; Pressure Controlled Ventilation (PC) and Pressure Regulated Volume
      Controlled ventilation (PRVC) in order to observe which of the two ventilation strategies
      results in a more stable ICP and arterial CO2 pressure (PaCO2).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>ICP</measure>
    <time_frame>Two hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Each study period is two hours. All patients receive several study periods (max number 6) in a N=1 design</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PaCO2</measure>
    <time_frame>Two hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Each subject is studied in several study periods each of two hours duration (max number 6 periods). N=1 design</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <arm_group>
    <arm_group_label>PC ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention with pressure controlled ventilator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PRVC ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention with Pressure Regulated Volume Controlled Ventilator</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>pressure controlled ventilator</intervention_name>
    <arm_group_label>PC ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pressure Regulated Volume Controlled Ventilator</intervention_name>
    <arm_group_label>PRVC ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent obtained from the patients next-of-kin.

          -  moderate or severe TBI according to Head Injury Severity Scale (Glasgow Coma Scale
             (GCS) score 3-13).

          -  treated at the neurosurgical ICU or the main ICU at St Olav University Hospital.

          -  intubated and receiving controlled mechanical ventilation.

          -  continuous measurement of ICP with either an intraventricular or an intraparenchymal
             pressure monitor device.

          -  sedation to a level of sedation corresponding to MAAS (Motor Activity Assessment
             Score) 0 or 1 with continuous intravenous infusions of midazolam/propofol and
             morphine/fentanyl/remifentanil14.

        Exclusion Criteria:

          -  Pregnancy

          -  ICP above 25 mmHg

          -  ongoing cerebral anti edema therapy corresponding to Step III at St Olav University
             Hospital therapy guideline

          -  continuous external drainage of cerebrospinal fluid (CSF)

          -  Clinical pulmonary condition prohibiting changes in respiratory therapy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pål Klepstad, MD Ph D</last_name>
    <role>Principal Investigator</role>
    <affiliation>NTNU</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept Intensive Care Medicine, St Olavs University Hospital</name>
      <address>
        <city>Trondheim</city>
        <zip>7006</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pål Klepstad, MB PhD</last_name>
      <phone>+47 72575709</phone>
      <email>pal.klepstad@ntnu.no</email>
    </contact>
    <investigator>
      <last_name>Kari Shirmer-Mikalsen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 27, 2013</lastchanged_date>
  <firstreceived_date>September 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Traumatic brain injury</keyword>
  <keyword>Intracranial pressure</keyword>
  <keyword>Ventilation</keyword>
  <keyword>Respiratory therapy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
